Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology symbols : PHAT save search
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Published: 2024-04-03 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: -0.31%
H: 2.35%
C: 0.92%
conference pharmaceuticals
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
Published: 2024-03-26 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 2.3%
H: 6.7%
C: -1.78%
pharmaceuticals
SIGA Names Larry Miller General Counsel
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
SIGA | $8.6 -1.83% 160K
|
Health Technology
|
| O: -7.42%
H: 5.73%
C: 2.96%
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 2.09%
H: 0.98%
C: -7.11%
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-03-07 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 7.81%
H: 0.67%
C: -13.35%
business year update pharmaceuticals financial results
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
Published: 2024-02-29 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.83%
H: 2.67%
C: -1.56%
report business year update pharmaceuticals financial results
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Tablets for Erosive GERD and Associated Heartburn Added to Express Scripts National Formularies for Commercial Patients
Published: 2024-02-13 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: -0.47%
H: 0.0%
C: -2.82%
voquezna scripts express pharmaceuticals commercial
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 4.1%
H: 1.34%
C: -5.77%
conference pharmaceuticals
Phathom Pharmaceuticals Announces Expansion of Existing Loan and Security Agreement with Hercules Capital
Published: 2023-12-14 (Crawled : 13:00) - globenewswire.com
HTGC 4 | $18.875 0.13% 340K
|
Finance
|
| O: 0.9%
H: 2.57%
C: 1.08%
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.36%
H: 12.29%
C: 7.59%
security pharmaceuticals expansion agreement
Phathom Pharmaceuticals Announces FDA Acceptance for Filing of VOQUEZNA® (vonoprazan) Tablets New Drug Application for the Treatment of Heartburn Associated with Non-Erosive GERD
Published: 2023-12-06 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: -5.99%
voquezna fda drug treatment pharmaceuticals application
Phathom Pharmaceuticals Announces Commercial Availability of VOQUEZNA® (vonoprazan) Tablets, a Powerful First-In-Class PCAB for the Treatment of Erosive GERD and Relief of Associated Heartburn
Published: 2023-11-28 (Crawled : 13:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.42%
H: 3.86%
C: -1.1%
voquezna treatment pharmaceuticals commercial
Phathom Pharmaceuticals Reports Third Quarter 2023 Results and Recent Business Updates
Published: 2023-11-09 (Crawled : 13:00) - globenewswire.com
HTGC 4 | $18.875 0.13% 340K
|
Finance
|
| O: 0.5%
H: 0.62%
C: -1.13%
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 7.16%
H: 7.88%
C: -6.21%
business pharmaceuticals results
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Treatment of Erosive GERD and Relief of Heartburn Associated with Erosive GERD in Adults
Published: 2023-11-01 (Crawled : 21:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 3.33%
H: 3.22%
C: -19.64%
voquezna fda approval treatment pharmaceuticals
Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNA® TRIPLE PAK®
Published: 2023-10-30 (Crawled : 14:00) - biospace.com/
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 1.04%
H: 5.94%
C: 2.63%
voquezna fda approval pharmaceuticals
Phathom Pharmaceuticals Announces FDA Approval of Reformulated Vonoprazan Tablets for VOQUEZNA® TRIPLE PAK® (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA® DUAL PAK® (vonoprazan, amoxicillin) for the Treatment of H. pylori Infection in Adults
Published: 2023-10-30 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 1.04%
H: 5.94%
C: 2.63%
voquezna fda approval infection treatment pharmaceuticals
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences - October 25, 2023
Published: 2023-10-25 (Crawled : 14:30) - biospace.com/
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.77%
H: 1.3%
C: -2.17%
pharmaceuticals
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2023-10-25 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.77%
H: 1.3%
C: -2.17%
pharmaceuticals
Phathom Pharmaceuticals Announces Vonoprazan NDA Submission for Non-Erosive GERD
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: -1.81%
H: 5.93%
C: -0.29%
pharmaceuticals submission
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
MS | News 0 d | $93.38 -0.41% 1.8M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.0%
H: 1.69%
C: -6.27%
pharmaceuticals
WE ALERT: Levi & Korsinsky, LLP Announces an Investigation of Wework, Inc.
Published: 2023-08-25 (Crawled : 22:00) - prnewswire.com
WE | $0.8355 -24.73% 35.25% 0
|
| Email alert
Add to watchlist
PHAT | $9.165 1.16% 170K
|
Health Technology
| Email alert
Add to watchlist
OPAD 4 | $7.46 0.54% 6.3K
|
Real Estate and Rental and Leas...
| Email alert
Add to watchlist
Phathom Pharmaceuticals Announces Submission of Six-Month Stability Data in Support of Erosive GERD New Drug Application
Published: 2023-08-21 (Crawled : 12:00) - globenewswire.com
PHAT | $9.165 1.16% 170K
|
Health Technology
|
| O: 0.0%
H: 4.97%
C: 1.69%
drug pharmaceuticals application submission
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.